Evidence-based residential treatment for gaming disorder (WHO ICD-11) within Switzerland's private therapeutic institutions
SwissAtlas operates exclusively as a non-medical coordination platform. We do not provide clinical services, diagnoses, or treatment recommendations. All medical decisions are made by licensed Swiss institutions following independent assessment.
For strategic context, review the confidential healthcare coordination Switzerland pillar to understand governance, confidentiality standards, and non-clinical coordination boundaries across specialties.
Gaming disorder was formally recognised by the World Health Organization in 2019 and included in the International Classification of Diseases (ICD-11) as a condition characterised by impaired control over gaming, increasing priority given to gaming over other activities, and continuation or escalation of gaming despite negative consequences. The condition must persist for at least twelve months (or less if symptoms are severe) to meet diagnostic criteria.
While the majority of gamers do not develop problematic patterns, a minority — estimated at 3–5% of gamers globally — develop compulsive gaming behaviours that significantly impair social, occupational, educational, and personal functioning. Gaming disorder is particularly prevalent among adolescents and young adults, but is increasingly recognised in adult professional populations, including technology-sector executives and professionals in high-cognitive-demand roles.
The neurobiological basis of gaming disorder involves dysregulation of dopamine reward pathways similar to substance addictions, with neuroimaging studies demonstrating structural and functional brain changes in individuals with severe gaming disorder.
Families and senior professionals often delay first contact because confidentiality concerns, professional exposure, and institutional suitability are not always clear at the start. Some individuals are also uncertain how to proceed when treatment requires cross-border planning and formal admission sequencing. A structured Swiss pathway helps reduce ambiguity by organizing documentation, clarifying roles, and creating a controlled referral process under licensed institutional oversight. This allows decisions to be made calmly, discreetly, and within a defined governance framework.
Swiss residential treatment for gaming disorder begins with thorough psychiatric assessment to evaluate the severity of gaming behaviour, screen for co-occurring conditions (ADHD, depression, social anxiety, autism spectrum traits), assess cognitive function, and develop an individualised treatment plan.
Treatment typically involves a period of complete digital withdrawal — removal of access to gaming devices, internet gaming platforms, and associated digital triggers. This structured withdrawal phase allows neurological reward pathways to begin normalising and creates space for therapeutic engagement.
Evidence-based approaches include cognitive-behavioural therapy for internet and gaming disorder (CBT-IG), motivational enhancement, social skills training, family therapy, structured activity scheduling (replacing gaming with healthy alternatives), and development of a sustainable relationship with technology. Treatment addresses underlying psychological needs that gaming was serving — social connection, achievement, escape, identity — and develops healthier strategies for meeting these needs.
Beyond the clinical framework, practical admission considerations often shape when and how families proceed with residential care planning.
Residential treatment for gaming disorder in Switzerland typically ranges from four to eight weeks. Programmes for adolescents may be longer and include educational components. Swiss privacy protections apply fully. Costs typically range from CHF 20,000 to CHF 50,000 per month. Family involvement is an important component, with Swiss institutions offering structured family therapy and psychoeducation.
Pricing depends on clinical complexity, length of stay, institutional protocols, and accommodation level. All cost estimates are indicative and subject to individual clinical assessment by the treating institution. SwissAtlas does not determine or negotiate treatment fees.
This pathway may involve medically supervised assessment and treatment planning by licensed Swiss clinicians using recognized evidence-based standards. Specific protocol selection remains institution-dependent and is determined only after independent clinical evaluation.
From a coordination perspective, SwissAtlas focuses on clear admission sequencing, secure information flow, and administrative continuity. We do not define treatment protocols and do not intervene in clinical judgment.
Addiction-related cases can affect high-functioning individuals with board, family, or reputational responsibilities. In that context, clarity of process is as important as confidentiality. SwissAtlas supports a calm and structured non-clinical pathway so administrative decisions, documentation flow, and admission logistics remain controlled from first intake to institutional handover.
Private treatment institutions in Switzerland operate under a dual regulatory architecture combining federal obligations and cantonal licensing oversight. All licensed institutions are required to comply with Swiss federal and cantonal regulation for patient safety, quality control, and operational accountability.
The Swiss Federal Act on Data Protection (FADP, revised 2023) sets strict requirements for processing and handling sensitive health information. In parallel, Swiss Criminal Code Article 321 enforces medical professional secrecy and establishes criminal sanctions for unauthorized disclosure of protected medical information.
Within this framework, SwissAtlas remains institutionally neutral. We do not provide clinical advice, do not recommend specific institutions, and do not influence medical decisions. Our role is limited to administrative access coordination, secure documentation handling, and international logistics support.
Governance-sensitive cases are often managed by family offices, board-level stakeholders, and legal advisors who require process clarity, controlled disclosure, and documented decision pathways. SwissAtlas structures the admission workflow to align with these governance requirements.
The coordination model emphasizes reputational risk mitigation through restricted-access communication, sequenced documentation flow, and role-based information governance. This structure supports institutional referral quality while minimizing unnecessary exposure of sensitive personal or corporate information.
For cross-border matters, SwissAtlas coordinates non-clinical timelines, document routing, and logistics so that institutional admission can proceed through a structured pathway consistent with private Swiss governance expectations.
Switzerland offers political neutrality, legal stability, and enforceable confidentiality protections that are highly relevant for governance-sensitive healthcare admissions. Its multilingual medical environment and established international reputation support structured cross-border coordination under a predictable institutional framework.
Gaming disorder is classified in the WHO International Classification of Diseases, 11th Revision (ICD-11) under code 6C51, categorised within 'Disorders due to addictive behaviours.' Diagnostic criteria require a pattern of persistent or recurrent gaming behaviour with impaired control, increasing priority over other activities, and continuation despite negative consequences — sufficiently severe to cause significant functional impairment, typically present for at least twelve months. The DSM-5 includes 'Internet Gaming Disorder' in Section III as a condition for further study.
The behavioural addiction model recognises that compulsive gaming engages neurobiological reward pathways — particularly dopaminergic circuits — similarly to substance addictions. Neuroimaging research demonstrates structural and functional brain changes in individuals with gaming disorder. Swiss treatment institutions apply this evidence-based framework, utilising therapeutic approaches adapted from substance addiction treatment including cognitive-behavioural therapy, motivational interviewing, and impulse control strategies, while addressing the specific digital and social dynamics of gaming behaviour.
CBT is a primary therapeutic modality in gaming disorder treatment, addressing distorted cognitions about gaming (perceived achievement, social identity, escape mechanisms), developing alternative coping strategies, building real-world social skills, establishing healthy digital use boundaries, and managing triggers and cravings. Swiss residential programmes combine individual CBT with group therapy, experiential activities, and structured digital detox periods.
Residential treatment for gaming disorder in Switzerland typically ranges from four to eight weeks. This period allows for comprehensive assessment, therapeutic intervention, development of alternative behavioural patterns, and structured transition planning. Extended programmes may be recommended for complex cases involving significant psychiatric comorbidity or previous treatment history.
Private residential gaming addiction treatment typically ranges from CHF 20,000 to CHF 50,000 per month. As a behavioural addiction programme without medical detoxification requirements, costs are generally lower than substance dependence treatment. Pricing depends on programme intensity, accommodation level, and institutional protocols.
Research indicates significant comorbidity between gaming disorder and attention-deficit/hyperactivity disorder (ADHD), social anxiety disorder, depressive disorders, and autism spectrum traits. Swiss institutions conduct comprehensive psychiatric evaluation to identify co-occurring conditions, which are addressed within integrated treatment frameworks rather than sequentially.
SwissAtlas facilitates administrative coordination: confidential enquiry processing, documentation handling, institutional introductions for facilities with behavioural addiction expertise, logistical arrangements, and aftercare coordination. SwissAtlas does not assess gaming behaviour or recommend treatment approaches. All clinical evaluation is conducted by the treating institution.
Related pages: Addiction Treatment Overview · Executive Rehab · Alcohol Rehab · Healthcare · Private Coordination · Process · Coordination Framework
SwissAtlas is a non-medical coordination platform registered in Switzerland. SwissAtlas does not provide medical advice, clinical assessment, diagnostic services, treatment recommendations, or any form of healthcare service. All information presented on this page is provided for general educational and informational purposes only and does not constitute medical advice or a substitute for professional medical consultation.
SwissAtlas does not evaluate, rank, endorse, recommend, or express any preference regarding any medical institution, healthcare provider, clinical programme, or treatment modality. The coordination services provided by SwissAtlas are exclusively non-clinical and administrative in nature.
All medical decisions are the sole responsibility of the patient and their chosen medical professionals. Patients are strongly encouraged to seek independent medical advice from qualified healthcare professionals before making any healthcare decisions.